HomeNewsBusinessCan IT firms expect the large deal momentum to continue in coming months?

Can IT firms expect the large deal momentum to continue in coming months?

Top IT majors recorded one of their largest pipelines, most of them in digital, amid the pandemic than in the previous year.

December 29, 2020 / 08:10 IST
Story continues below Advertisement
4. Hyderabad | Weighted Average Compensation: Rs 8.5 lakh per year (Image: Moneycontrol)
4. Hyderabad | Weighted Average Compensation: Rs 8.5 lakh per year (Image: Moneycontrol)

Top IT majors recorded one of their largest pipelines, most of them in digital, amid the pandemic than in the previous year. Going by the recent deal announcements, Q3 is likely to be as good, if not stronger for some.

Analysts expect these deal closures to result in an upgrade in revenue outlook for Q4 FY21 and also FY22.

Story continues below Advertisement

What are we talking about?

On December 22, Bengaluru-based IT majors Infosys and Wipro signed large deal with German firms Daimler and Metro respectively. In both the deals, the IT majors will take over the captive centres of their German clients and will help them transform their IT infrastructure.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show